Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.
about
Universal influenza vaccines, a dream to be realized soon.Emerging influenza viruses and the prospect of a universal influenza virus vaccine.Coated protein nanoclusters from influenza H7N9 HA are highly immunogenic and induce robust protective immunity.Production of H5N1 Influenza Virus Matrix Protein 2 Ectodomain Protein Bodies in Tobacco Plants and in Insect Cells as a Candidate Universal Influenza Vaccine.Biomaterial Strategies for Immunomodulation.Protein nanoparticles for therapeutic protein delivery.Dual-linker gold nanoparticles as adjuvanting carriers for multivalent display of recombinant influenza hemagglutinin trimers and flagellin improve the immunological responses in vivo and in vitro.Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.Effects of ovalbumin protein nanoparticle vaccine size and coating on dendritic cell processing.Double-layered protein nanoparticles induce broad protection against divergent influenza A viruses.Host- and pathogen-derived adjuvant coatings on protein nanoparticle vaccines.Sequential immunizations with a panel of HIV-1 Env virus-like particles coach immune system to make broadly neutralizing antibodies.Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in miceEnhancing T cell therapy through TCR-signaling-responsive nanoparticle drug deliveryCombination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccineH7 Hemagglutinin nanoparticles retain immunogenicity after >3 months of 25°C storage
P2860
Q30361950-FB9005A7-0D5F-4FFC-B0DD-1E4249BFEDD2Q30372274-73F94808-340E-4842-87DE-7828583A6622Q30392895-99D6687F-D855-4588-9C39-B47DFDCCA2C7Q36352851-6BFBC8CD-2FC6-4AC9-BCC3-22D17461AC74Q36703124-0E4BCE5F-1698-46A3-916D-8E11BF61E8B7Q38556744-830E6778-C74A-4B0B-B8A0-3A40799A5A1FQ40121454-3EEB4131-C59E-49C6-9EAD-ACD2036E4316Q40157020-67ADBAF5-A5F6-4C4A-8E7E-320012442C30Q47253016-23641575-FAEA-4D3E-B811-215813D179EEQ47549109-528C7DA5-E835-4753-B3A5-05F2E1AE3E09Q50995525-A704DE37-6D86-4DF5-8C7D-FFD4034976E8Q54207383-BBE3A716-3F1E-48C2-9D5B-FC48CA5531AAQ56221441-18F76959-A57A-4A8B-BCF2-AAE76A9181B3Q56797729-F1590E4D-5225-40B4-AC4D-515693D54D5AQ56989454-00078D61-5C1F-448E-B29D-5359C4CFE389Q58794262-06482F5A-F888-484C-BEB0-F8939634C5DD
P2860
Nanoclusters self-assembled from conformation-stabilized influenza M2e as broadly cross-protective influenza vaccines.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanoclusters self-assembled fr ...... protective influenza vaccines.
@en
Nanoclusters self-assembled fr ...... protective influenza vaccines.
@nl
type
label
Nanoclusters self-assembled fr ...... protective influenza vaccines.
@en
Nanoclusters self-assembled fr ...... protective influenza vaccines.
@nl
prefLabel
Nanoclusters self-assembled fr ...... protective influenza vaccines.
@en
Nanoclusters self-assembled fr ...... protective influenza vaccines.
@nl
P2093
P2860
P1476
Nanoclusters self-assembled fr ...... protective influenza vaccines.
@en
P2093
Annie Hess
Bao-Zhong Wang
Julie A Champion
Richard W Compans
Timothy Z Chang
Ying-Chun Wang
P2860
P304
P356
10.1016/J.NANO.2013.08.005
P577
2013-08-27T00:00:00Z